About MHAT Plovdiv
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Genentech, Inc.
2
Bausch Health Americas, Inc.
1
Futura Medical Developments Ltd.
1
Galapagos NV
1
Terumo Europe N.V.
1
Verona Pharma plc
1
Vifor Pharma
1
Clinical Trials at MHAT Plovdiv
During the past decade, MHAT Plovdiv conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
Study of Phosphate Levels in Patients With Chronic Kidney Disease
2008-12-01
2010-03-01
Completed
154
Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
2009-10-01
2010-09-01
Terminated
1,050
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
2010-01-01
2013-03-01
Completed
956
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
2011-09-01
2014-06-01
Completed
323
Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry
2014-06-01
2020-06-01
Unknown status
37,000
Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects
2015-04-01
2016-06-01
Completed
188
A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
2017-01-19
2019-07-16
Completed
260
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MHAT Plovdiv" #1 sponsor was "Pfizer" with 4 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored, "Futura Medical Developments Ltd." with 1 trials sponsored and "Galapagos NV"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Plovdiv"
#1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MHAT Plovdiv
According to Clinical.Site data, the most researched conditions in "MHAT Plovdiv" are
"Arthritis, Rheumatoid" (3 trials), "Systemic Lupus Erythematosus" (2 trials), "Chronic Kidney Disease" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "MHAT Plovdiv" in a lesser frequency.
Clinical Trials Intervention Types at MHAT Plovdiv
Most popular intervention types in "MHAT Plovdiv" are "Drug" (10 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "CP-690,550" (2 trials), "GDC-0853" (2 trials), "1.25 g PA21 (250 mg iron)" (1 trials) and "10.0 g PA21 (2,000 mg iron)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MHAT Plovdiv
The vast majority of trials in "MHAT Plovdiv" are
10 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at MHAT Plovdiv
Currently, there are NaN active trials in "MHAT Plovdiv".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in MHAT Plovdiv,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in MHAT Plovdiv, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".